Skip to main content
Equibles

PANAGORA ASSET MANAGEMENT INC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 883677 Boston, MA
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$17,985,921
+$2,656,595 QoQ
Shares Held
710,906
+3.2% QoQ
Ownership
0.413%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#37
of 354 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 11% Shared 0% None 89%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $623,499,718 across 77 Biotechnology names. ACAD ranks #10 (2.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 175,291 $109,300,950
2 INCY
Incyte Corp
 881,889 $99,970,937
3 XENE
Xenon Pharmaceuticals Inc.
 664,031 $40,080,911
4 MIRM
Mirum Pharmaceuticals, Inc.
 337,461 $39,506,559
5 TVTX
Travere Therapeutics, Inc.
 490,724 $27,878,030
6 JAZZ
Jazz Pharmaceuticals plc
 104,935 $25,286,186
7 RLAY
Relay Therapeutics, Inc.
 1,291,182 $24,158,015
8 CLDX
Celldex Therapeutics, Inc.
 572,538 $21,304,138

All Filings in ACAD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,985,921 710,906
2026-03-31 $15,329,326 688,649
2025-12-31 $18,192,234 681,102
2025-09-30 $14,016,816 656,833
2025-06-30 $14,110,964 654,194
2025-03-31 $10,858,936 653,759
2024-12-31 $12,021,837 655,141
2024-09-30 $10,199,585 663,172
2024-06-30 $10,755,387 661,870
2024-03-31 $12,966,889 701,292
2023-12-31 $20,192,445 644,920
2023-09-30 $13,400,078 642,998
2023-06-30 $16,170,105 675,161
2023-03-31 $13,700,978 728,001
2022-12-31 $10,835,231 680,605
2022-09-30 $10,755,783 657,444
2022-06-30 $9,112,947 646,767
2022-03-31 $11,622,742 479,882
2021-12-31 $9,350,424 400,618
2021-09-30 $6,793,921 409,026
2021-06-30 $9,910,315 406,327
2021-03-31 $118,576 4,596
2020-06-30 $170,711 3,522
2020-03-31 $1,162,128 27,506